CELL IMMUNOL 润色咨询

CELLULAR IMMUNOLOGY

出版年份:1970 年文章数:1628 投稿命中率: 开通期刊会员,数据随心看

出版周期:Monthly 自引率:1.1% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2142659, encodeId=3949214265963, content=昨天投了一篇,2小时候就被拒稿了,说有临床数据不适合发, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=936e4881173, createdName=758880040, createdTime=Wed Jun 14 00:30:01 CST 2023, time=2023-06-14, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=495628, encodeId=321f49562895, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享:投出去2周左右没有修改就直接接收了!之前投了一篇4分左右的,三篇2-3分的,其间还revised两次,最终都没有接受,CIMM却直接接受。出乎我的意料!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=488, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu May 09 15:37:00 CST 2013, time=2013-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953114, encodeId=162d95311490, content=刚刚在这个期刊投稿,希望有好消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210128/984d0c46dfef4f05bbb5cf7b10a10bb9/d8c733491a044887bfa168a0cdbb65ac.jpg, createdBy=de335316732, createdName=能帮我发SCI嘛, createdTime=Thu Apr 01 16:49:06 CST 2021, time=2021-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1231294, encodeId=2a3b123129428, content=官网写的 First decision是14天,但是超过了,还是with editor,状态都没变过,要催一下吗?着急毕业,要拒稿也迅速点啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5d375190834, createdName=14717fcdm36(暂无昵称), createdTime=Fri Jul 08 10:30:29 CST 2022, time=2022-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964720, encodeId=6f42964e2035, content=偏重的研究方向: 免疫 <br>经验分享:4月6日投稿,under review后日期变动三次,4月16日,4月28日,5月1日,现在还是under review。本来就是赶时间节点,奔着首页介绍的2.4week给first decision去投的,结果现在还没消息。昨天发了催稿信,编辑也没有答复,束手无策只能祈求上天保佑了!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d3f75495663, createdName=ms7000000254587858, createdTime=Tue May 11 20:47:57 CST 2021, time=2021-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088492, encodeId=5c161088492f0, content=关键词最少几个?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088491, encodeId=ac4d1088491ad, content=关键词最多不能超过多少个?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=954393, encodeId=a0f295439371, content=该期刊每月能收到50份稿件,每年出版100篇,所以接收率为1/6。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210128/984d0c46dfef4f05bbb5cf7b10a10bb9/d8c733491a044887bfa168a0cdbb65ac.jpg, createdBy=de335316732, createdName=能帮我发SCI嘛, createdTime=Wed Apr 07 08:56:57 CST 2021, time=2021-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552282, encodeId=96905522829b, content=With editor三天了 要悲剧了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=337, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fe0a1684792, createdName=小圆宝, createdTime=Fri Feb 02 17:10:00 CST 2018, time=2018-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552231, encodeId=c09155223121, content=后来怎样了啊<span class="quote">mlzhangedu 2017-07-10 发表::<br>SCI(2014):1.924SCI(2015):2.399SCI(2016):3.172 投出去7天了.还是with editor</span>, beContent=mlzhangedu 2017-07-10 发表:: SCI(2014):1.924SCI(2015):2.399SCI(2016):3.172 投出去7天了.还是with editor, objectType=tool_impact_factor, channel=null, level=null, likeNumber=382, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fe0a1684792, createdName=小圆宝, createdTime=Wed Jan 31 21:39:00 CST 2018, time=2018-01-31, status=1, ipAttribution=)]
    2023-06-14 758880040 来自江苏省

    昨天投了一篇,2小时候就被拒稿了,说有临床数据不适合发

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2142659, encodeId=3949214265963, content=昨天投了一篇,2小时候就被拒稿了,说有临床数据不适合发, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=936e4881173, createdName=758880040, createdTime=Wed Jun 14 00:30:01 CST 2023, time=2023-06-14, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=495628, encodeId=321f49562895, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享:投出去2周左右没有修改就直接接收了!之前投了一篇4分左右的,三篇2-3分的,其间还revised两次,最终都没有接受,CIMM却直接接受。出乎我的意料!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=488, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu May 09 15:37:00 CST 2013, time=2013-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953114, encodeId=162d95311490, content=刚刚在这个期刊投稿,希望有好消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210128/984d0c46dfef4f05bbb5cf7b10a10bb9/d8c733491a044887bfa168a0cdbb65ac.jpg, createdBy=de335316732, createdName=能帮我发SCI嘛, createdTime=Thu Apr 01 16:49:06 CST 2021, time=2021-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1231294, encodeId=2a3b123129428, content=官网写的 First decision是14天,但是超过了,还是with editor,状态都没变过,要催一下吗?着急毕业,要拒稿也迅速点啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5d375190834, createdName=14717fcdm36(暂无昵称), createdTime=Fri Jul 08 10:30:29 CST 2022, time=2022-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964720, encodeId=6f42964e2035, content=偏重的研究方向: 免疫 <br>经验分享:4月6日投稿,under review后日期变动三次,4月16日,4月28日,5月1日,现在还是under review。本来就是赶时间节点,奔着首页介绍的2.4week给first decision去投的,结果现在还没消息。昨天发了催稿信,编辑也没有答复,束手无策只能祈求上天保佑了!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d3f75495663, createdName=ms7000000254587858, createdTime=Tue May 11 20:47:57 CST 2021, time=2021-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088492, encodeId=5c161088492f0, content=关键词最少几个?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088491, encodeId=ac4d1088491ad, content=关键词最多不能超过多少个?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=954393, encodeId=a0f295439371, content=该期刊每月能收到50份稿件,每年出版100篇,所以接收率为1/6。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210128/984d0c46dfef4f05bbb5cf7b10a10bb9/d8c733491a044887bfa168a0cdbb65ac.jpg, createdBy=de335316732, createdName=能帮我发SCI嘛, createdTime=Wed Apr 07 08:56:57 CST 2021, time=2021-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552282, encodeId=96905522829b, content=With editor三天了 要悲剧了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=337, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fe0a1684792, createdName=小圆宝, createdTime=Fri Feb 02 17:10:00 CST 2018, time=2018-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552231, encodeId=c09155223121, content=后来怎样了啊<span class="quote">mlzhangedu 2017-07-10 发表::<br>SCI(2014):1.924SCI(2015):2.399SCI(2016):3.172 投出去7天了.还是with editor</span>, beContent=mlzhangedu 2017-07-10 发表:: SCI(2014):1.924SCI(2015):2.399SCI(2016):3.172 投出去7天了.还是with editor, objectType=tool_impact_factor, channel=null, level=null, likeNumber=382, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fe0a1684792, createdName=小圆宝, createdTime=Wed Jan 31 21:39:00 CST 2018, time=2018-01-31, status=1, ipAttribution=)]
    2013-05-09 匿名用户

    审稿速度:1.0 | 投稿命中率:75.0
    经验分享:投出去2周左右没有修改就直接接收了!之前投了一篇4分左右的,三篇2-3分的,其间还revised两次,最终都没有接受,CIMM却直接接受。出乎我的意料!

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2142659, encodeId=3949214265963, content=昨天投了一篇,2小时候就被拒稿了,说有临床数据不适合发, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=936e4881173, createdName=758880040, createdTime=Wed Jun 14 00:30:01 CST 2023, time=2023-06-14, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=495628, encodeId=321f49562895, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享:投出去2周左右没有修改就直接接收了!之前投了一篇4分左右的,三篇2-3分的,其间还revised两次,最终都没有接受,CIMM却直接接受。出乎我的意料!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=488, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu May 09 15:37:00 CST 2013, time=2013-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953114, encodeId=162d95311490, content=刚刚在这个期刊投稿,希望有好消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210128/984d0c46dfef4f05bbb5cf7b10a10bb9/d8c733491a044887bfa168a0cdbb65ac.jpg, createdBy=de335316732, createdName=能帮我发SCI嘛, createdTime=Thu Apr 01 16:49:06 CST 2021, time=2021-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1231294, encodeId=2a3b123129428, content=官网写的 First decision是14天,但是超过了,还是with editor,状态都没变过,要催一下吗?着急毕业,要拒稿也迅速点啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5d375190834, createdName=14717fcdm36(暂无昵称), createdTime=Fri Jul 08 10:30:29 CST 2022, time=2022-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964720, encodeId=6f42964e2035, content=偏重的研究方向: 免疫 <br>经验分享:4月6日投稿,under review后日期变动三次,4月16日,4月28日,5月1日,现在还是under review。本来就是赶时间节点,奔着首页介绍的2.4week给first decision去投的,结果现在还没消息。昨天发了催稿信,编辑也没有答复,束手无策只能祈求上天保佑了!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d3f75495663, createdName=ms7000000254587858, createdTime=Tue May 11 20:47:57 CST 2021, time=2021-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088492, encodeId=5c161088492f0, content=关键词最少几个?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088491, encodeId=ac4d1088491ad, content=关键词最多不能超过多少个?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=954393, encodeId=a0f295439371, content=该期刊每月能收到50份稿件,每年出版100篇,所以接收率为1/6。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210128/984d0c46dfef4f05bbb5cf7b10a10bb9/d8c733491a044887bfa168a0cdbb65ac.jpg, createdBy=de335316732, createdName=能帮我发SCI嘛, createdTime=Wed Apr 07 08:56:57 CST 2021, time=2021-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552282, encodeId=96905522829b, content=With editor三天了 要悲剧了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=337, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fe0a1684792, createdName=小圆宝, createdTime=Fri Feb 02 17:10:00 CST 2018, time=2018-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552231, encodeId=c09155223121, content=后来怎样了啊<span class="quote">mlzhangedu 2017-07-10 发表::<br>SCI(2014):1.924SCI(2015):2.399SCI(2016):3.172 投出去7天了.还是with editor</span>, beContent=mlzhangedu 2017-07-10 发表:: SCI(2014):1.924SCI(2015):2.399SCI(2016):3.172 投出去7天了.还是with editor, objectType=tool_impact_factor, channel=null, level=null, likeNumber=382, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fe0a1684792, createdName=小圆宝, createdTime=Wed Jan 31 21:39:00 CST 2018, time=2018-01-31, status=1, ipAttribution=)]
    2021-04-01 能帮我发SCI嘛

    刚刚在这个期刊投稿,希望有好消息

    8

    展开8条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=2142659, encodeId=3949214265963, content=昨天投了一篇,2小时候就被拒稿了,说有临床数据不适合发, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=936e4881173, createdName=758880040, createdTime=Wed Jun 14 00:30:01 CST 2023, time=2023-06-14, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=495628, encodeId=321f49562895, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享:投出去2周左右没有修改就直接接收了!之前投了一篇4分左右的,三篇2-3分的,其间还revised两次,最终都没有接受,CIMM却直接接受。出乎我的意料!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=488, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu May 09 15:37:00 CST 2013, time=2013-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953114, encodeId=162d95311490, content=刚刚在这个期刊投稿,希望有好消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210128/984d0c46dfef4f05bbb5cf7b10a10bb9/d8c733491a044887bfa168a0cdbb65ac.jpg, createdBy=de335316732, createdName=能帮我发SCI嘛, createdTime=Thu Apr 01 16:49:06 CST 2021, time=2021-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1231294, encodeId=2a3b123129428, content=官网写的 First decision是14天,但是超过了,还是with editor,状态都没变过,要催一下吗?着急毕业,要拒稿也迅速点啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5d375190834, createdName=14717fcdm36(暂无昵称), createdTime=Fri Jul 08 10:30:29 CST 2022, time=2022-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964720, encodeId=6f42964e2035, content=偏重的研究方向: 免疫 <br>经验分享:4月6日投稿,under review后日期变动三次,4月16日,4月28日,5月1日,现在还是under review。本来就是赶时间节点,奔着首页介绍的2.4week给first decision去投的,结果现在还没消息。昨天发了催稿信,编辑也没有答复,束手无策只能祈求上天保佑了!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d3f75495663, createdName=ms7000000254587858, createdTime=Tue May 11 20:47:57 CST 2021, time=2021-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088492, encodeId=5c161088492f0, content=关键词最少几个?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088491, encodeId=ac4d1088491ad, content=关键词最多不能超过多少个?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=954393, encodeId=a0f295439371, content=该期刊每月能收到50份稿件,每年出版100篇,所以接收率为1/6。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210128/984d0c46dfef4f05bbb5cf7b10a10bb9/d8c733491a044887bfa168a0cdbb65ac.jpg, createdBy=de335316732, createdName=能帮我发SCI嘛, createdTime=Wed Apr 07 08:56:57 CST 2021, time=2021-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552282, encodeId=96905522829b, content=With editor三天了 要悲剧了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=337, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fe0a1684792, createdName=小圆宝, createdTime=Fri Feb 02 17:10:00 CST 2018, time=2018-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552231, encodeId=c09155223121, content=后来怎样了啊<span class="quote">mlzhangedu 2017-07-10 发表::<br>SCI(2014):1.924SCI(2015):2.399SCI(2016):3.172 投出去7天了.还是with editor</span>, beContent=mlzhangedu 2017-07-10 发表:: SCI(2014):1.924SCI(2015):2.399SCI(2016):3.172 投出去7天了.还是with editor, objectType=tool_impact_factor, channel=null, level=null, likeNumber=382, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fe0a1684792, createdName=小圆宝, createdTime=Wed Jan 31 21:39:00 CST 2018, time=2018-01-31, status=1, ipAttribution=)]
    2022-07-08 14717fcdm36(暂无昵称)

    官网写的 First decision是14天,但是超过了,还是with editor,状态都没变过,要催一下吗?着急毕业,要拒稿也迅速点啊

    2

    展开2条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=2142659, encodeId=3949214265963, content=昨天投了一篇,2小时候就被拒稿了,说有临床数据不适合发, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=936e4881173, createdName=758880040, createdTime=Wed Jun 14 00:30:01 CST 2023, time=2023-06-14, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=495628, encodeId=321f49562895, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享:投出去2周左右没有修改就直接接收了!之前投了一篇4分左右的,三篇2-3分的,其间还revised两次,最终都没有接受,CIMM却直接接受。出乎我的意料!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=488, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu May 09 15:37:00 CST 2013, time=2013-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953114, encodeId=162d95311490, content=刚刚在这个期刊投稿,希望有好消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210128/984d0c46dfef4f05bbb5cf7b10a10bb9/d8c733491a044887bfa168a0cdbb65ac.jpg, createdBy=de335316732, createdName=能帮我发SCI嘛, createdTime=Thu Apr 01 16:49:06 CST 2021, time=2021-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1231294, encodeId=2a3b123129428, content=官网写的 First decision是14天,但是超过了,还是with editor,状态都没变过,要催一下吗?着急毕业,要拒稿也迅速点啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5d375190834, createdName=14717fcdm36(暂无昵称), createdTime=Fri Jul 08 10:30:29 CST 2022, time=2022-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964720, encodeId=6f42964e2035, content=偏重的研究方向: 免疫 <br>经验分享:4月6日投稿,under review后日期变动三次,4月16日,4月28日,5月1日,现在还是under review。本来就是赶时间节点,奔着首页介绍的2.4week给first decision去投的,结果现在还没消息。昨天发了催稿信,编辑也没有答复,束手无策只能祈求上天保佑了!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d3f75495663, createdName=ms7000000254587858, createdTime=Tue May 11 20:47:57 CST 2021, time=2021-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088492, encodeId=5c161088492f0, content=关键词最少几个?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088491, encodeId=ac4d1088491ad, content=关键词最多不能超过多少个?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=954393, encodeId=a0f295439371, content=该期刊每月能收到50份稿件,每年出版100篇,所以接收率为1/6。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210128/984d0c46dfef4f05bbb5cf7b10a10bb9/d8c733491a044887bfa168a0cdbb65ac.jpg, createdBy=de335316732, createdName=能帮我发SCI嘛, createdTime=Wed Apr 07 08:56:57 CST 2021, time=2021-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552282, encodeId=96905522829b, content=With editor三天了 要悲剧了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=337, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fe0a1684792, createdName=小圆宝, createdTime=Fri Feb 02 17:10:00 CST 2018, time=2018-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552231, encodeId=c09155223121, content=后来怎样了啊<span class="quote">mlzhangedu 2017-07-10 发表::<br>SCI(2014):1.924SCI(2015):2.399SCI(2016):3.172 投出去7天了.还是with editor</span>, beContent=mlzhangedu 2017-07-10 发表:: SCI(2014):1.924SCI(2015):2.399SCI(2016):3.172 投出去7天了.还是with editor, objectType=tool_impact_factor, channel=null, level=null, likeNumber=382, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fe0a1684792, createdName=小圆宝, createdTime=Wed Jan 31 21:39:00 CST 2018, time=2018-01-31, status=1, ipAttribution=)]
    2021-05-11 ms7000000254587858

    偏重的研究方向: 免疫
    经验分享:4月6日投稿,under review后日期变动三次,4月16日,4月28日,5月1日,现在还是under review。本来就是赶时间节点,奔着首页介绍的2.4week给first decision去投的,结果现在还没消息。昨天发了催稿信,编辑也没有答复,束手无策只能祈求上天保佑了!

    9

    展开9条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=2142659, encodeId=3949214265963, content=昨天投了一篇,2小时候就被拒稿了,说有临床数据不适合发, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=936e4881173, createdName=758880040, createdTime=Wed Jun 14 00:30:01 CST 2023, time=2023-06-14, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=495628, encodeId=321f49562895, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享:投出去2周左右没有修改就直接接收了!之前投了一篇4分左右的,三篇2-3分的,其间还revised两次,最终都没有接受,CIMM却直接接受。出乎我的意料!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=488, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu May 09 15:37:00 CST 2013, time=2013-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953114, encodeId=162d95311490, content=刚刚在这个期刊投稿,希望有好消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210128/984d0c46dfef4f05bbb5cf7b10a10bb9/d8c733491a044887bfa168a0cdbb65ac.jpg, createdBy=de335316732, createdName=能帮我发SCI嘛, createdTime=Thu Apr 01 16:49:06 CST 2021, time=2021-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1231294, encodeId=2a3b123129428, content=官网写的 First decision是14天,但是超过了,还是with editor,状态都没变过,要催一下吗?着急毕业,要拒稿也迅速点啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5d375190834, createdName=14717fcdm36(暂无昵称), createdTime=Fri Jul 08 10:30:29 CST 2022, time=2022-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964720, encodeId=6f42964e2035, content=偏重的研究方向: 免疫 <br>经验分享:4月6日投稿,under review后日期变动三次,4月16日,4月28日,5月1日,现在还是under review。本来就是赶时间节点,奔着首页介绍的2.4week给first decision去投的,结果现在还没消息。昨天发了催稿信,编辑也没有答复,束手无策只能祈求上天保佑了!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d3f75495663, createdName=ms7000000254587858, createdTime=Tue May 11 20:47:57 CST 2021, time=2021-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088492, encodeId=5c161088492f0, content=关键词最少几个?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088491, encodeId=ac4d1088491ad, content=关键词最多不能超过多少个?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=954393, encodeId=a0f295439371, content=该期刊每月能收到50份稿件,每年出版100篇,所以接收率为1/6。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210128/984d0c46dfef4f05bbb5cf7b10a10bb9/d8c733491a044887bfa168a0cdbb65ac.jpg, createdBy=de335316732, createdName=能帮我发SCI嘛, createdTime=Wed Apr 07 08:56:57 CST 2021, time=2021-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552282, encodeId=96905522829b, content=With editor三天了 要悲剧了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=337, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fe0a1684792, createdName=小圆宝, createdTime=Fri Feb 02 17:10:00 CST 2018, time=2018-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552231, encodeId=c09155223121, content=后来怎样了啊<span class="quote">mlzhangedu 2017-07-10 发表::<br>SCI(2014):1.924SCI(2015):2.399SCI(2016):3.172 投出去7天了.还是with editor</span>, beContent=mlzhangedu 2017-07-10 发表:: SCI(2014):1.924SCI(2015):2.399SCI(2016):3.172 投出去7天了.还是with editor, objectType=tool_impact_factor, channel=null, level=null, likeNumber=382, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fe0a1684792, createdName=小圆宝, createdTime=Wed Jan 31 21:39:00 CST 2018, time=2018-01-31, status=1, ipAttribution=)]
    2021-12-28 MS68862005

    关键词最少几个?

    1

    展开1条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=2142659, encodeId=3949214265963, content=昨天投了一篇,2小时候就被拒稿了,说有临床数据不适合发, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=936e4881173, createdName=758880040, createdTime=Wed Jun 14 00:30:01 CST 2023, time=2023-06-14, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=495628, encodeId=321f49562895, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享:投出去2周左右没有修改就直接接收了!之前投了一篇4分左右的,三篇2-3分的,其间还revised两次,最终都没有接受,CIMM却直接接受。出乎我的意料!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=488, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu May 09 15:37:00 CST 2013, time=2013-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953114, encodeId=162d95311490, content=刚刚在这个期刊投稿,希望有好消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210128/984d0c46dfef4f05bbb5cf7b10a10bb9/d8c733491a044887bfa168a0cdbb65ac.jpg, createdBy=de335316732, createdName=能帮我发SCI嘛, createdTime=Thu Apr 01 16:49:06 CST 2021, time=2021-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1231294, encodeId=2a3b123129428, content=官网写的 First decision是14天,但是超过了,还是with editor,状态都没变过,要催一下吗?着急毕业,要拒稿也迅速点啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5d375190834, createdName=14717fcdm36(暂无昵称), createdTime=Fri Jul 08 10:30:29 CST 2022, time=2022-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964720, encodeId=6f42964e2035, content=偏重的研究方向: 免疫 <br>经验分享:4月6日投稿,under review后日期变动三次,4月16日,4月28日,5月1日,现在还是under review。本来就是赶时间节点,奔着首页介绍的2.4week给first decision去投的,结果现在还没消息。昨天发了催稿信,编辑也没有答复,束手无策只能祈求上天保佑了!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d3f75495663, createdName=ms7000000254587858, createdTime=Tue May 11 20:47:57 CST 2021, time=2021-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088492, encodeId=5c161088492f0, content=关键词最少几个?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088491, encodeId=ac4d1088491ad, content=关键词最多不能超过多少个?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=954393, encodeId=a0f295439371, content=该期刊每月能收到50份稿件,每年出版100篇,所以接收率为1/6。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210128/984d0c46dfef4f05bbb5cf7b10a10bb9/d8c733491a044887bfa168a0cdbb65ac.jpg, createdBy=de335316732, createdName=能帮我发SCI嘛, createdTime=Wed Apr 07 08:56:57 CST 2021, time=2021-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552282, encodeId=96905522829b, content=With editor三天了 要悲剧了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=337, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fe0a1684792, createdName=小圆宝, createdTime=Fri Feb 02 17:10:00 CST 2018, time=2018-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552231, encodeId=c09155223121, content=后来怎样了啊<span class="quote">mlzhangedu 2017-07-10 发表::<br>SCI(2014):1.924SCI(2015):2.399SCI(2016):3.172 投出去7天了.还是with editor</span>, beContent=mlzhangedu 2017-07-10 发表:: SCI(2014):1.924SCI(2015):2.399SCI(2016):3.172 投出去7天了.还是with editor, objectType=tool_impact_factor, channel=null, level=null, likeNumber=382, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fe0a1684792, createdName=小圆宝, createdTime=Wed Jan 31 21:39:00 CST 2018, time=2018-01-31, status=1, ipAttribution=)]
    2021-12-27 msSSSSSD

    关键词最多不能超过多少个?

    1

    展开1条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=2142659, encodeId=3949214265963, content=昨天投了一篇,2小时候就被拒稿了,说有临床数据不适合发, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=936e4881173, createdName=758880040, createdTime=Wed Jun 14 00:30:01 CST 2023, time=2023-06-14, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=495628, encodeId=321f49562895, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享:投出去2周左右没有修改就直接接收了!之前投了一篇4分左右的,三篇2-3分的,其间还revised两次,最终都没有接受,CIMM却直接接受。出乎我的意料!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=488, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu May 09 15:37:00 CST 2013, time=2013-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953114, encodeId=162d95311490, content=刚刚在这个期刊投稿,希望有好消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210128/984d0c46dfef4f05bbb5cf7b10a10bb9/d8c733491a044887bfa168a0cdbb65ac.jpg, createdBy=de335316732, createdName=能帮我发SCI嘛, createdTime=Thu Apr 01 16:49:06 CST 2021, time=2021-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1231294, encodeId=2a3b123129428, content=官网写的 First decision是14天,但是超过了,还是with editor,状态都没变过,要催一下吗?着急毕业,要拒稿也迅速点啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5d375190834, createdName=14717fcdm36(暂无昵称), createdTime=Fri Jul 08 10:30:29 CST 2022, time=2022-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964720, encodeId=6f42964e2035, content=偏重的研究方向: 免疫 <br>经验分享:4月6日投稿,under review后日期变动三次,4月16日,4月28日,5月1日,现在还是under review。本来就是赶时间节点,奔着首页介绍的2.4week给first decision去投的,结果现在还没消息。昨天发了催稿信,编辑也没有答复,束手无策只能祈求上天保佑了!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d3f75495663, createdName=ms7000000254587858, createdTime=Tue May 11 20:47:57 CST 2021, time=2021-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088492, encodeId=5c161088492f0, content=关键词最少几个?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088491, encodeId=ac4d1088491ad, content=关键词最多不能超过多少个?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=954393, encodeId=a0f295439371, content=该期刊每月能收到50份稿件,每年出版100篇,所以接收率为1/6。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210128/984d0c46dfef4f05bbb5cf7b10a10bb9/d8c733491a044887bfa168a0cdbb65ac.jpg, createdBy=de335316732, createdName=能帮我发SCI嘛, createdTime=Wed Apr 07 08:56:57 CST 2021, time=2021-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552282, encodeId=96905522829b, content=With editor三天了 要悲剧了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=337, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fe0a1684792, createdName=小圆宝, createdTime=Fri Feb 02 17:10:00 CST 2018, time=2018-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552231, encodeId=c09155223121, content=后来怎样了啊<span class="quote">mlzhangedu 2017-07-10 发表::<br>SCI(2014):1.924SCI(2015):2.399SCI(2016):3.172 投出去7天了.还是with editor</span>, beContent=mlzhangedu 2017-07-10 发表:: SCI(2014):1.924SCI(2015):2.399SCI(2016):3.172 投出去7天了.还是with editor, objectType=tool_impact_factor, channel=null, level=null, likeNumber=382, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fe0a1684792, createdName=小圆宝, createdTime=Wed Jan 31 21:39:00 CST 2018, time=2018-01-31, status=1, ipAttribution=)]
    2021-04-07 能帮我发SCI嘛

    该期刊每月能收到50份稿件,每年出版100篇,所以接收率为1/6。

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=2142659, encodeId=3949214265963, content=昨天投了一篇,2小时候就被拒稿了,说有临床数据不适合发, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=936e4881173, createdName=758880040, createdTime=Wed Jun 14 00:30:01 CST 2023, time=2023-06-14, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=495628, encodeId=321f49562895, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享:投出去2周左右没有修改就直接接收了!之前投了一篇4分左右的,三篇2-3分的,其间还revised两次,最终都没有接受,CIMM却直接接受。出乎我的意料!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=488, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu May 09 15:37:00 CST 2013, time=2013-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953114, encodeId=162d95311490, content=刚刚在这个期刊投稿,希望有好消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210128/984d0c46dfef4f05bbb5cf7b10a10bb9/d8c733491a044887bfa168a0cdbb65ac.jpg, createdBy=de335316732, createdName=能帮我发SCI嘛, createdTime=Thu Apr 01 16:49:06 CST 2021, time=2021-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1231294, encodeId=2a3b123129428, content=官网写的 First decision是14天,但是超过了,还是with editor,状态都没变过,要催一下吗?着急毕业,要拒稿也迅速点啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5d375190834, createdName=14717fcdm36(暂无昵称), createdTime=Fri Jul 08 10:30:29 CST 2022, time=2022-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964720, encodeId=6f42964e2035, content=偏重的研究方向: 免疫 <br>经验分享:4月6日投稿,under review后日期变动三次,4月16日,4月28日,5月1日,现在还是under review。本来就是赶时间节点,奔着首页介绍的2.4week给first decision去投的,结果现在还没消息。昨天发了催稿信,编辑也没有答复,束手无策只能祈求上天保佑了!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d3f75495663, createdName=ms7000000254587858, createdTime=Tue May 11 20:47:57 CST 2021, time=2021-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088492, encodeId=5c161088492f0, content=关键词最少几个?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088491, encodeId=ac4d1088491ad, content=关键词最多不能超过多少个?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=954393, encodeId=a0f295439371, content=该期刊每月能收到50份稿件,每年出版100篇,所以接收率为1/6。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210128/984d0c46dfef4f05bbb5cf7b10a10bb9/d8c733491a044887bfa168a0cdbb65ac.jpg, createdBy=de335316732, createdName=能帮我发SCI嘛, createdTime=Wed Apr 07 08:56:57 CST 2021, time=2021-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552282, encodeId=96905522829b, content=With editor三天了 要悲剧了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=337, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fe0a1684792, createdName=小圆宝, createdTime=Fri Feb 02 17:10:00 CST 2018, time=2018-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552231, encodeId=c09155223121, content=后来怎样了啊<span class="quote">mlzhangedu 2017-07-10 发表::<br>SCI(2014):1.924SCI(2015):2.399SCI(2016):3.172 投出去7天了.还是with editor</span>, beContent=mlzhangedu 2017-07-10 发表:: SCI(2014):1.924SCI(2015):2.399SCI(2016):3.172 投出去7天了.还是with editor, objectType=tool_impact_factor, channel=null, level=null, likeNumber=382, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fe0a1684792, createdName=小圆宝, createdTime=Wed Jan 31 21:39:00 CST 2018, time=2018-01-31, status=1, ipAttribution=)]
    2018-02-02 小圆宝

    With editor三天了 要悲剧了吗

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=2142659, encodeId=3949214265963, content=昨天投了一篇,2小时候就被拒稿了,说有临床数据不适合发, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=936e4881173, createdName=758880040, createdTime=Wed Jun 14 00:30:01 CST 2023, time=2023-06-14, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=495628, encodeId=321f49562895, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享:投出去2周左右没有修改就直接接收了!之前投了一篇4分左右的,三篇2-3分的,其间还revised两次,最终都没有接受,CIMM却直接接受。出乎我的意料!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=488, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu May 09 15:37:00 CST 2013, time=2013-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953114, encodeId=162d95311490, content=刚刚在这个期刊投稿,希望有好消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210128/984d0c46dfef4f05bbb5cf7b10a10bb9/d8c733491a044887bfa168a0cdbb65ac.jpg, createdBy=de335316732, createdName=能帮我发SCI嘛, createdTime=Thu Apr 01 16:49:06 CST 2021, time=2021-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1231294, encodeId=2a3b123129428, content=官网写的 First decision是14天,但是超过了,还是with editor,状态都没变过,要催一下吗?着急毕业,要拒稿也迅速点啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5d375190834, createdName=14717fcdm36(暂无昵称), createdTime=Fri Jul 08 10:30:29 CST 2022, time=2022-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964720, encodeId=6f42964e2035, content=偏重的研究方向: 免疫 <br>经验分享:4月6日投稿,under review后日期变动三次,4月16日,4月28日,5月1日,现在还是under review。本来就是赶时间节点,奔着首页介绍的2.4week给first decision去投的,结果现在还没消息。昨天发了催稿信,编辑也没有答复,束手无策只能祈求上天保佑了!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d3f75495663, createdName=ms7000000254587858, createdTime=Tue May 11 20:47:57 CST 2021, time=2021-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088492, encodeId=5c161088492f0, content=关键词最少几个?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088491, encodeId=ac4d1088491ad, content=关键词最多不能超过多少个?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=954393, encodeId=a0f295439371, content=该期刊每月能收到50份稿件,每年出版100篇,所以接收率为1/6。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210128/984d0c46dfef4f05bbb5cf7b10a10bb9/d8c733491a044887bfa168a0cdbb65ac.jpg, createdBy=de335316732, createdName=能帮我发SCI嘛, createdTime=Wed Apr 07 08:56:57 CST 2021, time=2021-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552282, encodeId=96905522829b, content=With editor三天了 要悲剧了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=337, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fe0a1684792, createdName=小圆宝, createdTime=Fri Feb 02 17:10:00 CST 2018, time=2018-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552231, encodeId=c09155223121, content=后来怎样了啊<span class="quote">mlzhangedu 2017-07-10 发表::<br>SCI(2014):1.924SCI(2015):2.399SCI(2016):3.172 投出去7天了.还是with editor</span>, beContent=mlzhangedu 2017-07-10 发表:: SCI(2014):1.924SCI(2015):2.399SCI(2016):3.172 投出去7天了.还是with editor, objectType=tool_impact_factor, channel=null, level=null, likeNumber=382, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fe0a1684792, createdName=小圆宝, createdTime=Wed Jan 31 21:39:00 CST 2018, time=2018-01-31, status=1, ipAttribution=)]
    2018-01-31 小圆宝

    后来怎样了啊mlzhangedu 2017-07-10 发表::
    SCI(2014):1.924SCI(2015):2.399SCI(2016):3.172 投出去7天了.还是with editor

    mlzhangedu 2017-07-10 发表:: SCI(2014):1.924SCI(2015):2.399SCI(2016):3.172 投出去7天了.还是with editor

    0

共41条页码: 1/5页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分